Stockscreener 앱 받기
8.63
5.89%
-0.54
시간 외 거래:
8.63
Olema Pharmaceuticals Inc 주식(OLMA)의 최신 뉴스
Olema Pharmaceuticals stock hits 52-week low at $8.51 - Investing.com
What is Lifesci Capital’s Estimate for OLMA FY2025 Earnings? - Defense World
Equities Analysts Issue Forecasts for OLMA FY2024 Earnings - Defense World
Olema Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times
OLMAOlema Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Olema Oncology to Participate in Upcoming Investor Conferences - The Manila Times
Olema Oncology to Present at Three Major Healthcare Investor Conferences | OLMA Stock News - StockTitan
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Average Recommendation of “Buy” by Brokerages - Defense World
Brokerages Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) PT at $27.00 - MarketBeat
Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation - Yahoo Finance
Possible Bearish Signals With Olema Pharmaceuticals Insiders Disposing Stock - Simply Wall St
SG Americas Securities LLC Acquires Shares of 13,056 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Pharmaceuticals (NASDAQ:OLMA) Earns Buy Rating from HC Wainwright - MarketBeat
Olema Pharmaceuticals maintains Buy rating from H.C. Wainwright By Investing.com - Investing.com UK
Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024 - The Manila Times
Insider Selling: Paradigm Biocapital Advisors L, Olema Pharmaceuticals Inc [OLMA] 10% Owner divested 2,400,000 shares – Knox Daily - Knox Daily
Closing Bell Recap: Olema Pharmaceuticals Inc (OLMA) Ends at 11.26, Reflecting a -1.23 Downturn - The Dwinnex
Can you still get a good price for Olema Pharmaceuticals Inc (OLMA) Shares at this point? - US Post News
Renaissance Technologies LLC Buys Shares of 53,200 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - The Manila Times
Point72 Asset Management L.P. Purchases New Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Aurigene Oncology, Olema Pharmaceuticals identify KAT6A inhibitors - BioWorld Online
Brokerages Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Target Price at $27.00 - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Dimensional Fund Advisors LP - Defense World
OLMA Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
OLMA underperforms with a -4.07 decrease in share price - US Post News
74,657 Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Acquired by Dana Investment Advisors Inc. - MarketBeat
olema pharmaceuticals, inc. Earnings dates - RTTNews
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 3.8% - MarketBeat
Keeping an Eye on Olema Pharmaceuticals Inc (OLMA) After Insider Trading Activity - Knox Daily
Insider’s View: Deciphering Olema Pharmaceuticals Inc (OLMA)’s Financial Health Through Ratios - The Dwinnex
Long Term Trading Analysis for (OLMA) - Stock Traders Daily
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Purchased by Marshall Wace LLP - Defense World
Ensign Peak Advisors Inc Acquires 850 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Affinity Asset Advisors LLC Purchases Shares of 275,000 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Affinity Asset Advisors LLC Invests $2.98 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Rhumbline Advisers Buys 17,953 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Logos Global Management LP - Defense World
Great Point Partners LLC Takes Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Great Point Partners LLC Purchases New Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Examining the Potential Price Growth of Olema Pharmaceuticals Inc (OLMA) - Knox Daily
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 6.3% - Defense World
Taking the lead: Olema Pharmaceuticals Inc (OLMA) - SETE News
A Tale of Resilience: Olema Pharmaceuticals Inc Amid Stock Market Turbulence - The InvestChronicle
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Position Boosted by Bank of New York Mellon Corp - MarketBeat
Bank of New York Mellon Corp Acquires 58,622 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Market Insight: Olema Pharmaceuticals Inc (OLMA)’s Notable Gain, Closing at 12.27 - The Dwinnex
Olema Pharmaceuticals Inc’s results are impressive - US Post News
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Purchased by Victory Capital Management Inc. - Defense World
Victory Capital Management Inc. Has $8.38 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Analysts Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Target Price at $27.00 - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of “Buy” from Analysts - Defense World
3.66%
1.11%
자본화:
|
볼륨(24시간):